A casein diet added isoflavone-enriched soy protein favorably affects biomarkers of steatohepatitis in obese Zucker rats

Nutrition

Volumn 25, Issue 5, 2009, Pages 574-580

  Gudbrandsen, Oddrun Anita ^a   Wergedahl, Hege ^a   Berge, Rolf Kristian ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

Genistein; Inflammation; Isoflavones; Non alcoholic fatty liver disease; Obese Zucker rats; Soy protein

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILE ACID; CASEIN; COPPER; INTERLEUKIN 1BETA; ISOFLAVONE; LIPID PEROXIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; SOYBEAN PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET; DIET SUPPLEMENTATION; DISEASE MARKER; FATTY LIVER; HEPATITIS; LIPID PEROXIDATION; LIVER INJURY; MALE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; ZUCKER RAT;

ANIMALS; BIOLOGICAL MARKERS; CASEINS; DISEASE MODELS, ANIMAL; FATTY LIVER; HEPATITIS; ISOFLAVONES; LIPID METABOLISM; LIVER; MALE; OBESITY; RANDOM ALLOCATION; RATS; RATS, ZUCKER; RNA, MESSENGER; SOYBEAN PROTEINS; TRIGLYCERIDES;

RATTUS;

EID: 63049088091     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2008.10.020     Document Type: Article

References (48)

1. Haukeland J.W., Damas J.K., Konopski Z., Loberg E.M., Haaland T., Goverud I., et al. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J Hepatol 44 (2006) 1167-1174
2. Silverman J.F., O'Brien K.F., Long S., Leggett N., Khazanie P.G., Pories W.J., et al. Liver pathology in morbidly obese patients with and without diabetes. Am J Gastroenterol 85 (1990) 1349-1355
3. Angulo P., and Lindor K.D. Non-alcoholic fatty liver disease. J Gastroenterol Hepatol 17 suppl (2002) S186-S190
4. McClain C.J., Mokshagundam S.P., Barve S.S., Song Z., Hill D.B., Chen T., and Deaciuc I. Mechanisms of non-alcoholic steatohepatitis. Alcohol 34 (2004) 67-79
5. Nagata Y., Tanaka K., and Sugano M. Further studies on the hypocholesterolaemic effect of soya-bean protein in rats. Br J Nutr 45 (1981) 233-241
6. Nagata Y., Ishiwaki N., and Sugano M. Studies on the mechanism of antihypercholesterolemic action of soy protein and soy protein-type amino acid mixtures in relation to the casein counterparts in rats. J Nutr 112 (1982) 1614-1625
7. Tanaka K., Aso B., and Sugano M. Biliary steroid excretion in rats fed soybean protein and casein or their amino acid mixtures. J Nutr 114 (1984) 26-32
8. Madani S., Lopez S., Blond J.P., Prost J., and Belleville J. Highly purified soybean protein is not hypocholesterolemic in rats but stimulates cholesterol synthesis and excretion and reduces polyunsaturated fatty acid biosynthesis. J Nutr 128 (1998) 1084-1091
9. Wergedahl H., Liaset B., Gudbrandsen O.A., Lied E., Espe M., Muna Z., et al. Fish protein hydrolysate reduces plasma total cholesterol, increases the proportion of HDL cholesterol, and lowers acyl-CoA:cholesterol acyltransferase activity in liver of Zucker rats. J Nutr 134 (2004) 1320-1327
10. Gudbrandsen O.A., Wergedahl H., Mork S., Liaset B., Espe M., and Berge R.K. Dietary soya protein concentrate enriched with isoflavones reduced fatty liver, increased hepatic fatty acid oxidation and decreased the hepatic mRNA level of VLDL receptor in obese Zucker rats. Br J Nutr 96 (2006) 249-257
11. Gudbrandsen O.A., Wergedahl H., Liaset B., Espe M., and Berge R.K. Dietary proteins with high isoflavone content or low methionine-glycine and lysine-arginine ratios are hypocholesterolaemic and lower the plasma homocysteine level in male Zucker fa/fa rats. Br J Nutr 94 (2005) 321-330
12. Tilg H., and Diehl A.M. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 343 (2000) 1467-1476
13. Krief S., and Bazin R. Genetic obesity: is the defect in the sympathetic nervous system?. A review through developmental studies in the preobese Zucker rat. Proc Soc Exp Biol Med 198 (1991) 528-538
14. Hotamisligil G.S., Shargill N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
15. Trayhurn P., and Wood I.S. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans 33 (2005) 1078-1081
16. Kern P.A., Saghizadeh M., Ong J.M., Bosch R.J., Deem R., and Simsolo R.B. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 95 (1995) 2111-2119
17. Yamakawa T., Tanaka S., Yamakawa Y., Kiuchi Y., Isoda F., Kawamoto S., et al. Augmented production of tumor necrosis factor-alpha in obese mice. Clin Immunol Immunopathol 75 (1995) 51-56
18. Yang S.Q., Lin H.Z., Lane M.D., Clemens M., and Diehl A.M. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci U S A 94 (1997) 2557-2562
19. Huang Y., Cao S., Nagamani M., Anderson K.E., Grady J.J., and Lu L.J. Decreased circulating levels of tumor necrosis factor-alpha in postmenopausal women during consumption of soy-containing isoflavones. J Clin Endocrinol Metab 90 (2005) 3956-3962
20. Guo T.L., McCay J.A., Zhang L.X., Brown R.D., You L., Karrow N.A., et al. Genistein modulates immune responses and increases host resistance to B16F10 tumor in adult female B6C3F1 mice. J Nutr 131 (2001) 3251-3258
21. Guo T.L., White Jr. K.L., Brown R.D., Delclos K.B., Newbold R.R., Weis C., et al. Genistein modulates splenic natural killer cell activity, antibody-forming cell response, and phenotypic marker expression in F(0) and F(1) generations of Sprague-Dawley rats. Toxicol Appl Pharmacol 181 (2002) 219-227
22. Farrell G.C., and Larter C.Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43 (2006) S99-S112
23. Harrison S.A., Kadakia S., Lang K.A., and Schenker S. Nonalcoholic steatohepatitis: what we know in the new millennium. Am J Gastroenterol 97 (2002) 2714-2724
24. Erlanson-Albertsson C. The role of uncoupling proteins in the regulation of metabolism. Acta Physiol Scand 178 (2003) 405-412
25. Chavin K.D., Yang S., Lin H.Z., Chatham J., Chacko V.P., Hoek J.B., et al. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J Biol Chem 274 (1999) 5692-5700
26. Rashid A., Wu T.C., Huang C.C., Chen C.H., Lin H.Z., Yang S.Q., et al. Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology 29 (1999) 1131-1138
27. Baffy G. Uncoupling protein-2 and non-alcoholic fatty liver disease. Front Biosci 10 (2005) 2082-2096
28. Rashid A., Koteish A.K., Cortes-Pinto H., Wang X.T., Yang S., Coyle W., et al. Subcellular localization of uncoupling protein (UCP)2 and evidence for increased UCP2 expression in nonalcoholic steatohepatitis. Hepatology 30 (1999) 405A
29. Kohjima M., Enjoji M., Higuchi N., Kato M., Kotoh K., Yoshimoto T., et al. Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. Int J Mol Med 20 (2007) 351-358
30. Park J.W., Jeong G., Kim S.J., Kim M.K., and Park S.M. Predictors reflecting the pathological severity of non-alcoholic fatty liver disease: comprehensive study of clinical and immunohistochemical findings in younger Asian patients. J Gastroenterol Hepatol 22 (2007) 491-497
31. Wei H., Bowen R., Cai Q., Barnes S., and Wang Y. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med 208 (1995) 124-130
32. Tikkanen M.J., Wahala K., Ojala S., Vihma V., and Adlercreutz H. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc Natl Acad Sci U S A 95 (1998) 3106-3110
33. Wiseman H., O'Reilly J.D., Adlercreutz H., Mallet A.I., Bowey E.A., Rowland I.R., and Sanders T.A. Isoflavone phytoestrogens consumed in soy decrease F(2)-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr 72 (2000) 395-400
34. Jenkins D.J., Kendall C.W., Garsetti M., Rosenberg-Zand R.S., Jackson C.J., Agarwal S., et al. Effect of soy protein foods on low-density lipoprotein oxidation and ex vivo sex hormone receptor activity-a controlled crossover trial. Metabolism 49 (2000) 537-543
35. Bligh E.G., and Dyer W.J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37 (1959) 911-917
36. Chavali S.R., Zhong W.W., Utsunomiya T., and Forse R.A. Decreased production of interleukin-1-beta, prostaglandin-E2 and thromboxane-B2, and elevated levels of interleukin-6 and -10 are associated with increased survival during endotoxic shock in mice consuming diets enriched with sesame seed oil supplemented with Quil-A saponin. Int Arch Allergy Immunol 114 (1997) 153-160
37. Muna Z.A., Gudbrandsen O.A., Wergedahl H., Bohov P., Skorve J., and Berge R.K. Inhibition of rat lipoprotein oxidation after tetradecylthioacetic acid feeding. Biochem Pharmacol 63 (2002) 1127-1135
38. Esterbauer H., Striegl G., Puhl H., and Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 6 (1989) 67-75
39. Naveau S., Balian A., Capron F., Raynard B., Fallik D., Agostini H., et al. Balance between pro and anti-inflammatory cytokines in patients with acute alcoholic hepatitis. Gastroenterol Clin Biol 29 (2005) 269-274
40. Zhang L.J., and Wang X.Z. Interleukin-10 and chronic liver disease. World J Gastroenterol 12 (2006) 1681-1685
41. Zhu Y., Lin J.H., Liao H.L., Verna L., and Stemerman M.B. Activation of ICAM-1 promoter by lysophosphatidylcholine: possible involvement of protein tyrosine kinases. Biochim Biophys Acta 1345 (1997) 93-98
42. Collart M.A., Baeuerle P., and Vassalli P. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Mol Cell Biol 10 (1990) 1498-1506
43. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262 (1987) 5592-5595
44. Dixon R.A., and Ferreira D. Genistein. Phytochemistry 60 (2002) 205-211
45. Slukvin I.I., Boor P.J., and Jerrells T.R. Initiation of alcoholic fatty liver and hepatic inflammation with a specific recall immune response in alcohol-consuming C57Bl/6 mice. Clin Exp Immunol 125 (2001) 123-133
46. Glosli H., Gudbrandsen O.A., Mullen A.J., Halvorsen B., Rost T.H., Wergedahl H., et al. Down-regulated expression of PPARalpha target genes, reduced fatty acid oxidation and altered fatty acid composition in the liver of mice transgenic for hTNFalpha. Biochim Biophys Acta 1734 (2005) 235-246
47. Marsillach J., Bertran N., Camps J., Ferre N., Riu F., Tous M., et al. The role of circulating monocyte chemoattractant protein-1 as a marker of hepatic inflammation in patients with chronic liver disease. Clin Biochem 38 (2005) 1138-1140
48. Cortez-Pinto H., Zhi Lin H., Qi Yang S., Odwin Da Costa S., and Diehl A.M. Lipids up-regulate uncoupling protein 2 expression in rat hepatocytes. Gastroenterology 116 (1999) 1184-1193